Form 4: Dyadic VP Acquires Shares, Options in Compensation Move

Dyadic International's VP of Research and Business Development, Ronen Tchelet, acquired 18,064 shares of common stock and 47,250 stock options as part of his compensation.

Summary

• Ronen Tchelet, VP of Research and Business Development at Dyadic International Inc. (DYAI), reported transactions on January 2, 2026.
• Acquired 18,064 shares of common stock at a price of $0 per share, which were issued upon the vesting of Restricted Stock Units (RSUs).
• The RSUs were granted as part of the Issuer's key employee annual bonus, in lieu of a cash bonus earned for the year ended 2025, and vested in full upon grant.
• Acquired 47,250 stock options with an exercise price of $0.94 per option.
• These stock options represent an annual grant and will vest in one year, subject to continued service to the Issuer, with an expiration date of January 2, 2036.
• Following these transactions, Ronen Tchelet directly beneficially owns 50,897 shares of common stock and 47,250 stock options.

Sentiment

Score: 6

Explanation: Slightly positive. While the RSUs were in lieu of cash, the overall increase in insider equity ownership through both shares and options is generally viewed favorably as it aligns executive interests with shareholder value creation.

Positives

• Increased direct beneficial ownership by a key executive (VP of Research and Business Development) aligns management interests with shareholders.
• The grant of RSUs and stock options serves as a form of equity compensation, incentivizing long-term performance and retention of key personnel.

Negatives

• The RSUs were granted 'in lieu of a cash bonus' for 2025, which could suggest a preference to conserve cash or a strategic shift in compensation structure.

Future Outlook

The stock options granted on January 2, 2026, are subject to a one-year vesting period, contingent on continued service to the Issuer, indicating a future incentive for the executive.

Management Comments

• The company utilized Restricted Stock Units (RSUs) as part of its key employee annual bonus for the year ended 2025, issuing them in lieu of a cash bonus.

Industry Context

Equity compensation, including RSUs and stock options, is a standard practice across various industries for incentivizing and retaining key executives and aligning their interests with those of shareholders. This filing reflects a routine compensation event within this broader industry trend.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) and stock options for executive compensation is a common practice, aligning with global benchmarks for corporate governance and incentive structures.
• Many companies, including peers in the biotechnology and industrial enzymes sectors, utilize similar equity-based awards to reward performance and ensure long-term commitment from their leadership teams.

Related Party Transactions

• The acquisition of common stock and grant of stock options to Ronen Tchelet, a VP of Research and Business Development, constitutes a related party transaction as it involves compensation from the company to an executive officer.

Stakeholder Impact

• Shareholders: Increased insider ownership can signal confidence in the company's future, potentially aligning executive and shareholder interests. The issuance of new shares for RSUs could result in minor dilution.
• Employees (specifically Ronen Tchelet): Receives equity compensation, providing a direct stake in the company's performance and long-term incentive.

Next Steps

• The 47,250 stock options granted to Ronen Tchelet are expected to vest on January 2, 2027, subject to his continued service to Dyadic International.

Key Dates

Keywords

Dyadic International, DYAI, Ronen Tchelet, Form 4, Insider Transaction, Stock Options, Restricted Stock Units, Equity Compensation, Executive Compensation